FDA adds boldest warning to widely-used painkillers

WASHINGTON — Federal health regulators will add their strongest warning labels to the most widely-prescribed painkillers, part of a multi-pronged government campaign to stem an epidemic of abuse and death tied to drugs like Vicodin and Percocet.

The Food and Drug Administration announced Tuesday plans to add a boxed warning — the most serious type — to all immediate-release opioid painkillers, including some 175 branded and generic drugs.

Those medications, which often combine oxycodone with lower-grade medications, are among the most commonly used drugs in the U.S. and account for 90 percent of all opioid painkillers prescribed.

The long-awaited change comes roughly three years after the FDA added similar warnings to long-acting opioid drugs like OxyContin, which slowly release their doses over 12 hours or more. The labeling switch means both immediate and extended-release formulations will now highlight the risks of addiction, abuse, overdose and death.

“We’re at a time when the unfathomable tragedies resulting from addiction, overdose and death have become one of the most urgent and devastating public health crises facing our country,” FDA Commissioner Dr. Robert Califf said on a call with reporters. “I can’t stress enough how critical it is for prescribers to have the most current information.”

But lawmakers from states ravaged by opioid addiction said such labeling changes have “done little” to help their communities.

“Unfortunately, it has taken FDA far too long to address the grave risks of these drugs that have claimed the lives of thousands this year alone,” said Sen. Edward Markey, D-Mass.

Opioids are a class of powerful and highly-addictive drugs that include both prescription drugs like codeine and hydrocodone, as well as illegal narcotics, like heroin.

Deaths linked to misuse and abuse of prescription opioids climbed to 19,000 in 2014, the highest figure on record, according to the Centers for Disease Control and Prevention. Heroin and opioid painkillers combined caused 28,650 fatal overdoses.

Doctors are not required to follow the FDA’s instructions on drug labels, though they are often used as prescribing guidelines by hospitals, medical groups and insurers.

Critics of the FDA, including Physicians for Responsible Opioid Prescribing, called on the agency to add such warnings years ago.

“The main driver of our opioid epidemic is addiction, and the immediate-release products are just as addictive,” said the group’s founder, Dr. Andrew Kolodny, an addiction therapist with Phoenix House, a network of rehabilitation clinics.

The new FDA label will specify that the drugs like Percocet should only be used when other medications and alternative therapies cannot control patients’ pain.

“This new indication, once finalized, will remind prescribers that immediate-release opioids are also powerful drugs with important safety concerns,” said Dr. Doug Throckmorton, a deputy director in the FDA’s drug center.

Throckmorton said the agency’s 2013 labeling change focused on long-acting drugs like OxyContin because they represented a “disproportionate risk” to patients, since they contain larger opioid levels.

Government officials have tried a variety of approaches to tackling painkiller abuse in recent years. The FDA previously restricted combination pills like Vicodin to limit refills and who can prescribe them. States like Florida and New York have cracked down on “pill mills” using databases to monitor what doctors are prescribing.

In a separate briefing Tuesday, the Obama administration’s drug czar praised the move by the FDA and Califf, who was confirmed to lead the agency last month.

“I think we’re very heartened by the new director of the FDA and his enhanced focus on opioid issues,” said Michael Botticelli, National Drug Control Policy Director. “This is an all-of-government effort and clearly the FDA has a key role to play.”

In addition to the boxed warning, the FDA said it would add new information about the risks of opioid use for pregnant women and their newborns as well as drug interactions with antidepressants and other medications.

The FDA announcement comes less than a week after the CDC released the first-ever national prescribing guidelines for using opioids. The agency said primary care doctors should only turn to opioids after considering physical therapy, over-the-counter medications, counseling and other methods for treating chronic pain.

___

This story corrects the number of immediate-release opioids affected by the FDA action to 175, not 220.

More in News

(Juneau Empire file photo)
Aurora forecast for the week of March 18

These forecasts are courtesy of the University of Alaska Fairbanks’ Geophysical Institute… Continue reading

A board in the House Chambers at the Alaska State Capitol shows Monday’s vote tally of 39-20 to override Gov. Mike Dunleavy’s veto of Senate Bill 140, one vote short of the two-thirds necessary. (Mark Sabbatini / Juneau Empire)
Legislature fails by a single vote of 39-20 to override Gov. Mike Dunleavy’s veto of education bill

Legislators warn bad blood may hamper other issues as numerous Republicans abandon earlier support.

With COVID-19 aid, more schools gave students and families experiencing homelessness prepaid cards to buy necessities like groceries and gas. (Justin Sullivan / Getty Images)
Grocery cards and car repairs: How COVID aid changed the way schools can help homeless kids

Juneau student services specialist among those finding creative ways to provide assistance.

(Michael Penn / Juneau Empire file photo)
Police calls for Saturay, March 16, 2024

This report contains public information from law enforcement and public safety agencies.

(Michael Penn / Juneau Empire file photo)
Police calls for Friday, March 15, 2024

This report contains public information from law enforcement and public safety agencies.

Gov. Mike Dunleavy discusses his veto of a wide-ranging education bill during a press conference Friday at the Alaska State Capitol. (Mark Sabbatini / Juneau Empire)
Veto override vote on education bill expected to have consequences — and no assurance of extra funds

Retaliation by governor, fractured relationships within Legislature on other issues among concerns.

(Michael Penn / Juneau Empire file photo)
Police calls for Thursday, March 14, 2024

This report contains public information from law enforcement and public safety agencies.

Kaskanak Creek in the Bristol Bay’s Kvichak watershed is seen from the air on Sept. 27, 2011. Threats to the watershed and other sites were cited by the Environmental Protection Agency when it issued a decision barring permitting of the Pebble mine. But the Dunleavy administration and Northern Dynasty Minerals Ltd. have taken legal action to try to reverse that decision. (Photo provided by Environmental Protection Agency
State lawsuit claims federal government owes Alaska $700 billion for quashing Pebble mine

The federal government owes Alaska more than $700 billion in compensation for… Continue reading

Tongass National Forest (Photo by U.S. Forest Service)
New Department of Interior opinion promises to recognize expanded tribal jurisdiction in Alaska

Tribes can exert jurisdiction over allotments granted to individual Natives, opinion states.

Most Read